Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings
Condition: Diagnoses Disease Intervention: Device: HemoTypeSC Sponsor: Silver Lake Research Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Sickle Cell Anemia